Brokers Issue Forecasts for Aemetis FY2030 Earnings

Aemetis, Inc (NASDAQ:AMTX) – HC Wainwright issued their FY2030 EPS estimates for shares of Aemetis in a report released on Friday, March 13th. HC Wainwright analyst A. Dayal expects that the specialty chemicals company will post earnings of $3.05 per share for the year. The consensus estimate for Aemetis’ current full-year earnings is ($2.07) per share.

AMTX has been the topic of several other reports. Weiss Ratings restated a “sell (e+)” rating on shares of Aemetis in a research report on Wednesday, January 21st. Ascendiant Capital Markets reduced their price target on Aemetis from $21.00 to $20.00 and set a “buy” rating for the company in a research report on Wednesday, November 19th. Finally, Loop Capital set a $1.75 price target on Aemetis in a research note on Thursday. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Aemetis currently has a consensus rating of “Hold” and a consensus price target of $8.25.

Aemetis Trading Down 3.9%

Shares of NASDAQ AMTX opened at $2.20 on Monday. The stock has a 50 day simple moving average of $1.57 and a 200-day simple moving average of $1.89. The company has a market cap of $145.64 million, a PE ratio of -1.65 and a beta of 2.61. Aemetis has a 12-month low of $1.22 and a 12-month high of $3.66.

Aemetis (NASDAQ:AMTX) last announced its quarterly earnings results on Thursday, March 12th. The specialty chemicals company reported ($0.24) EPS for the quarter, beating the consensus estimate of ($0.28) by $0.04. The firm had revenue of $43.31 million during the quarter, compared to analyst estimates of $72.07 million.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Marshall Wace LLP increased its stake in shares of Aemetis by 289.3% during the fourth quarter. Marshall Wace LLP now owns 559,754 shares of the specialty chemicals company’s stock valued at $778,000 after acquiring an additional 415,978 shares during the period. Vanguard Group Inc. lifted its position in Aemetis by 15.3% in the third quarter. Vanguard Group Inc. now owns 2,479,163 shares of the specialty chemicals company’s stock worth $5,578,000 after purchasing an additional 329,760 shares during the period. Jane Street Group LLC bought a new position in Aemetis during the 2nd quarter valued at $634,000. CIBC Bancorp USA Inc. bought a new position in Aemetis during the 3rd quarter valued at $563,000. Finally, 683 Capital Management LLC acquired a new position in shares of Aemetis during the 4th quarter valued at $327,000. 27.02% of the stock is currently owned by institutional investors.

Aemetis Company Profile

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.